Marta Sabater-Martos

Dr. Marta Sabater-Martos

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2023 in Journal of Bone and Joint Infection
Verified
Journal Article
Open access
PDF file
CRChristen Ravn
Christen Ravn
JNJeroen Neyt
Jeroen Neyt
Natividad BenitoNatividad Benito
Natividad Benito
MAMiguel Araújo Abreu
Miguel Araújo Abreu
YAYvonne Achermann
Yvonne Achermann
ASAlex Soriano
Alex Soriano
This clinical guideline is intended for use by orthopedic surgeons and physicians who care for patients with possible or documented septic arthritis of a native joint (SANJO). It includes evidence and opinion-based recommendations for the diagnosis and management of patients with SANJO.

2 March 2023 in Arthroplasty
Verified
Journal Article
Open access
PDF file
MSMarta Sabater-Martos
Marta Sabater-Martos
MVMiguel A. Verdejo
Miguel A. Verdejo
LMLaura Morata
Laura Morata
EMErnesto Muñoz-Mahamud
Ernesto Muñoz-Mahamud
EGErnesto Guerra-Farfan
Ernesto Guerra-Farfan
ASAlex Soriano
Alex Soriano
Background: Excellent revisions about antibiotic-loaded bone cement (ALBC) have been recently published. In the present article, we review the principles and limitations of local antibiotic delivery in the context of recent advances in the pathogenesis of prosthetic joint infections (PJI), with particular attention paid to the potential association between ALBC and antimicrobial resistance. Main body: Recalcitrance of PJI is related to the ability of pathogens to adapt to particular environments present in bone tissue and protect themselves from host immunity in different ways. Accordingly, delivery of high local antimicrobial concentrations using ALBC is needed. Most relevant clinical data showing the efficacy of ALBC for PJI prophylaxis and treatment are reviewed, and we dissected the limitations on the basis of the recent findings from animal models and suggested that aminoglycosides, in particular, could not be the best option. One of the major concerns associated with ALBC is the emergence of resistance because of theoretical prolonged exposure to low antibiotic concentrations. We summarize the mechanisms for the selection of resistant microorganisms, and we critically reviewed the evidence from animal models and clinical data from observational and registry studies and concluded that there is no evidence to support this association. Conclusion: While waiting for better evidence from well-designed clinical trials, ALBC shows a beneficial effect as a prophylaxis in arthroplasty, and to avoid the colonization of spacers used for two-stage revision in patients with PJI. Experimental models and clinical evidence suggest the need to achieve high local antimicrobial concentrations to obtain the highest prophylactic and therapeutic effect. The current evidence does not support the risk of increasing resistance with use of ALBC. In the future, it is necessary to evaluate new carriers and different antimicrobials to improve clinical outcomes.

14 May 2025 in Journal of Bone and Joint Infection
Verified
Journal Article
Open access
PDF file
MSMarta Sabater-Martos
Marta Sabater-Martos
MCMartin Clauss
Martin Clauss
ARAna Ribau
Ana Ribau
RSRicardo Sousa
Ricardo Sousa
Introduction : Peri-prosthetic joint infection (PJI) is a significant complication of arthroplasty, lacking a single gold standard diagnostic test. Synovial fluid white blood cell (WBC) count and polymorphonuclear neutrophil (PMN) proportion are widely used diagnostic tools, but their optimal cutoffs remain unclear, particularly for chronic PJI. Material and methods : This systematic review and meta-analysis included 74 studies published between 2000 and 2024. Data on diagnostic performance (sensitivity, specificity, and diagnostic odds ratios – DORs) of WBC count and PMN proportions were analysed. Sub-group analyses and heterogeneity assessments were performed, and optimal cutoffs for diagnostic accuracy were identified. Results : The meta-analysis revealed a WBC count summary DOR of 58.38 (95 % CI – confidence interval: 48.48–70.32) with an area under the curve (AUC) of the summarized receiver operating characteristic curve of 0.952. The PMN proportion showed a DOR of 43.17 (95 % CI: 35.31–52.79) and an AUC of 0.941. Optimal diagnostic thresholds for chronic PJI were WBC count > 2600 cells per microlitre and PMN > 70 %. Rule-in thresholds (specificity >95 %) were WBC count ≥ 3000 cells per microlitre and PMN ≥ 75 %, while rule-out thresholds (sensitivity > 95 %) were WBC count ≤ 1500 cells per microlitre and PMN ≤ 65 %. Confounding conditions such as fractures, inflammatory arthritis, and metal-related reactions reduced test accuracy. Conclusions : Synovial fluid analysis remains a critical diagnostic tool for chronic PJI. Thresholds of WBC count < 1500 and >3000 cells per microlitre and PMN < 65 % and >75 % provide reliable negative and positive predictive values. A standardized diagnostic framework is essential for addressing remaining controversies and ensuring consistent interpretation across clinical settings.

1 June 2022 in Acta Orthopaedica Belgica
Verified
Journal Article
Open access
MBMaria Victoria Pomenta Bastidas
Maria Victoria Pomenta Bastidas
SSSergi Sastre
Sergi Sastre
JVJosep Maria Segur Vilalta
Josep Maria Segur Vilalta
JRJosé Ríos
José Ríos
MSMarta Sabater-Martos
Marta Sabater-Martos
DPDragos Popescu
Dragos Popescu
Recently there has been growing interest in the quadriceps tendon (QUAD) as a valid option for reconstruction of the anterior cruciate ligament (ACLR). The aims of the study is to compare the out- comes achieved in anatomic ACLR involving QUAD vs. Hamstring (HT) autografts. A total of 52 consecutive patients underwent an ACLR, 25 patients with QUAD graft and 27 with HT graft. The same surgical technique, fixation method and postoperative protocol were used in both groups. The following parameters were evaluated: functional status (Lysholm, Tegner, subjective IKDC scores), joint stability (Lachman and pivot shift tests), surgical reoperation rate, complications, degree of satisfaction and return to previous level of activity. Descriptive statistics were analysed using the Student’s t-test. Forty four patients were evaluated (20 QUAD, 24 HT), with a mean follow-up of 27.4 months. Two patients were re-operated in the QUAD group (including one ACL revision), and one patient in the HT group required an ACL revision. There were no significant differences between the two groups in postoperative scores: Lysholm (96.05 vs. 96.05), IKDC (86.2 vs. 91.2) and Tegner (6 vs. 5) scales. The percentage of negative Lachman and pivot shift tests was similar in the two groups (45% vs. 50% and 40% vs. 45.8%, respectively). There were no significant differences between the groups in the degree of satisfaction (95.8% vs. 80%, p = .16) or in the percentage who returned to their previous level of activity (62.5% vs. 45%, p = .17). The use of a QUAD graft in ACL reconstruction leads to similar clinical and functional outcomes to those obtained with HT.

10 October 2025 in Journal of Bone and Joint Infection
Verified
Journal Article
Open access
PDF file
ISIrene Sigmund
Irene Sigmund
MDMatthew J. Dietz
Matthew J. Dietz
MSMarta Sabater-Martos
Marta Sabater-Martos
APAntony J. R. Palmer
Antony J. R. Palmer
NCNicolas Cortés-Penfield
Nicolas Cortés-Penfield
TTThe “Serum Marker Workgroup” For The Unified Pji Definition Taskforce
The “Serum Marker Workgroup” For The Unified Pji Definition Taskforce
Aim: As part of a multi-society effort to derive a unified consensus definition of periprosthetic joint infection (PJI), a systematic review of serum inflammatory marker diagnostic performance for hip, knee, and shoulder PJI was performed. Methods: PubMed (MEDLINE) and EMBASE were searched for studies reporting the diagnostic performance of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), white blood cell count (WBC), fibrinogen, interleukin-6 (IL-6), or D-dimer for PJI. From these, each markers' pooled sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV), and area under the summary receiver operating characteristic curve (AUSROC) were calculated using a random-effects model. Results: A total of 89 studies reported all diagnostic performance measures for at least one marker. CRP (84 studies, 22 351 patients) demonstrated a pooled sensitivity, specificity, PPV, NPV, and AUSROC of 79.4 % (95 %CI: 78.5–80.3), 77.7 % (77.1–78.3), 67.0 % (63.3–70.7), 86.6 % (84.5–88.7), and 0.872 (SE 0.01), respectively. Corresponding performance estimates for fibrinogen (14 studies, 3433 patients) were 70.9 % (68.3–73.3), 85.9 % (84.3–87.3), 77.2 % (71.8–82.6), 82.1 % (77.1–87.2), and 0.889 (0.02), respectively, and those for IL-6 (20 studies, 2318 patients) were 76.3 % (73.4–79.0), 85.8 % (83.8–87.6), 74.5 % (69.0–80.0), 86.0 % (80.6–91.3), and 0.900 (0.01), respectively. ESR, D-dimer, and WBC did not offer greater predictive values than these markers. Conclusion: Although serum CRP, fibrinogen, and IL-6 demonstrated the best performance among all analysed parameters, their diagnostic accuracy remains insufficient to reliably confirm or exclude PJI. Elevated serum markers should be re-evaluated as a diagnostic criterion in future PJI definitions. Level of evidence: The level of evidence was Level III.

1 November 2020 in Revista Española de Cirugía Ortopédica y Traumatología
Verified
Journal Article
Closed access
MSMarta Sabater-Martos
Marta Sabater-Martos
JHJ.A. Hernández Hermoso
J.A. Hernández Hermoso
EOE. García Oltra
E. García Oltra
SMS. Molinos
S. Molinos
JMJ.C. Martínez-Pastor
J.C. Martínez-Pastor